141 related articles for article (PubMed ID: 37305828)
1. The histological assessment of new bone formation with zolendronic acid loaded bone allograft in rabbit femoral bone defect.
Saginova D; Tashmetov E; Kamyshanskiy Y; Koshanova A; Arutyunyan M; Rustambek I
J Med Life; 2023 Apr; 16(4):616-622. PubMed ID: 37305828
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Bone Regenerative Capacity in Rabbit Femoral Defect Using Thermally Disinfected Bone Human Femoral Head Combined with Platelet-Rich Plasma, Recombinant Human Bone Morphogenetic Protein 2, and Zoledronic Acid.
Saginova D; Tashmetov E; Kamyshanskiy Y; Tuleubayev B; Rimashevskiy D
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371824
[TBL] [Abstract][Full Text] [Related]
3. Modulation of bone formation and resorption using a novel zoledronic acid loaded gelatin nanoparticles integrated porous titanium scaffold: an in vitro and in vivo study.
Yang XJ; Wang FQ; Lu CB; Zou JW; Hu JB; Yang Z; Sang HX; Zhang Y
Biomed Mater; 2020 Jul; 15(5):055013. PubMed ID: 32252046
[TBL] [Abstract][Full Text] [Related]
4. Zoledronic acid prevents osteopenia and increases bone strength in a rabbit model of distraction osteogenesis.
Little DG; Smith NC; Williams PR; Briody JN; Bilston LE; Smith EJ; Gardiner EM; Cowell CT
J Bone Miner Res; 2003 Jul; 18(7):1300-7. PubMed ID: 12854841
[TBL] [Abstract][Full Text] [Related]
5. Skeletal histomorphometry in subjects on teriparatide or zoledronic acid therapy (SHOTZ) study: a randomized controlled trial.
Dempster DW; Zhou H; Recker RR; Brown JP; Bolognese MA; Recknor CP; Kendler DL; Lewiecki EM; Hanley DA; Rao DS; Miller PD; Woodson GC; Lindsay R; Binkley N; Wan X; Ruff VA; Janos B; Taylor KA
J Clin Endocrinol Metab; 2012 Aug; 97(8):2799-808. PubMed ID: 22701017
[TBL] [Abstract][Full Text] [Related]
6. Ozone Improved Bone Dynamic of Female Rats Using Zoledronate.
Lima Neto TJ; Delanora LA; Sá Simon ME; Carmo Ribeiro KH; Matsumoto MA; Quírino Louzada MJ; Shibli JA; Ervolino E; Faverani LP
Tissue Eng Part C Methods; 2024 Jan; 30(1):1-14. PubMed ID: 37933908
[TBL] [Abstract][Full Text] [Related]
7. Effect of zoledronate acid treatment on osseointegration and fixation of implants in autologous iliac bone grafts in ovariectomized rabbits.
Qi M; Hu J; Li J; Li J; Dong W; Feng X; Yu J
Bone; 2012 Jan; 50(1):119-27. PubMed ID: 22023930
[TBL] [Abstract][Full Text] [Related]
8. A single dose of zoledronic acid reverses the deleterious effects of glucocorticoids on titanium implant osseointegration.
Carvas JS; Pereira RM; Caparbo VF; Fuller P; Silveira CA; Lima LA; Bonfa E; Mello SB
Osteoporos Int; 2010 Oct; 21(10):1723-9. PubMed ID: 19997905
[TBL] [Abstract][Full Text] [Related]
9. Zoledronic acid enhances bone-implant osseointegration more than alendronate and strontium ranelate in ovariectomized rats.
Chen B; Li Y; Yang X; Xu H; Xie D
Osteoporos Int; 2013 Jul; 24(7):2115-21. PubMed ID: 23389695
[TBL] [Abstract][Full Text] [Related]
10. Effects of alendronate on bone formation and osteoclastic resorption after implantation of beta-tricalcium phosphate.
Tanaka T; Saito M; Chazono M; Kumagae Y; Kikuchi T; Kitasato S; Marumo K
J Biomed Mater Res A; 2010 May; 93(2):469-74. PubMed ID: 19582838
[TBL] [Abstract][Full Text] [Related]
11. Dose-Dependent Resorption of Allograft by rhBMP-2 Uncompensated by New Bone Formation-A Canine Study With Implants and Zoledronate.
Cleemann R; Bechtold JE; Sorensen M; Soballe K; Baas J
J Arthroplasty; 2018 Apr; 33(4):1215-1221.e1. PubMed ID: 29248483
[TBL] [Abstract][Full Text] [Related]
12. Histomorphometric description of allograft bone remodeling and union in a canine segmental femoral defect model: a comparison of rhBMP-2, cancellous bone graft, and absorbable collagen sponge.
Zabka AG; Pluhar GE; Edwards RB; Manley PA; Hayashi K; Heiner JP; Kalscheur VL; Seeherman HJ; Markel
J Orthop Res; 2001 Mar; 19(2):318-27. PubMed ID: 11347707
[TBL] [Abstract][Full Text] [Related]
13. Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogs.
Allen MR; Kubek DJ; Burr DB
J Bone Miner Res; 2010 Jan; 25(1):98-105. PubMed ID: 19580463
[TBL] [Abstract][Full Text] [Related]
14. Effect of Zoledronic Acid Application on Different Graft Materials in Calvarial Bone Defect Models. An Experimental Analysis.
Koparal M; Gülsün B; Deveci E; Agacayak KS; Hamidi A
Anal Quant Cytopathol Histpathol; 2016 Apr; 38(2):117-25. PubMed ID: 27386633
[TBL] [Abstract][Full Text] [Related]
15. PTH promotes allograft integration in a calvarial bone defect.
Sheyn D; Cohn Yakubovich D; Kallai I; Su S; Da X; Pelled G; Tawackoli W; Cook-Weins G; Schwarz EM; Gazit D; Gazit Z
Mol Pharm; 2013 Dec; 10(12):4462-71. PubMed ID: 24131143
[TBL] [Abstract][Full Text] [Related]
16. Zoledronic acid inhibits osteoclast differentiation and function through the regulation of NF-κB and JNK signalling pathways.
Huang XL; Huang LY; Cheng YT; Li F; Zhou Q; Wu C; Shi QH; Guan ZZ; Liao J; Hong W
Int J Mol Med; 2019 Aug; 44(2):582-592. PubMed ID: 31173157
[TBL] [Abstract][Full Text] [Related]
17. Early tissue responses to zoledronate, locally delivered by bone screw, into a compromised cancellous bone site: a pilot study.
Arnoldi J; Alves A; Procter P
BMC Musculoskelet Disord; 2014 Mar; 15():97. PubMed ID: 24656151
[TBL] [Abstract][Full Text] [Related]
18. Enhanced bone regeneration with a novel synthetic bone substitute in combination with a new natural cross-linked collagen membrane: radiographic and histomorphometric study.
Calvo-Guirado JL; Ramírez-Fernández MP; Maté-Sánchez JE; Bruno N; Velasquez P; de Aza PN
Clin Oral Implants Res; 2015 Apr; 26(4):454-464. PubMed ID: 24720519
[TBL] [Abstract][Full Text] [Related]
19. The effect of bisphosphonate and intermittent human parathyroid hormone 1-34 treatments on cortical bone allografts in rabbits.
Yamamoto Y; Washimi Y; Kanaji A; Tajima K; Ishimura D; Yamada H
J Endocrinol Invest; 2012 Feb; 35(2):139-45. PubMed ID: 21613814
[TBL] [Abstract][Full Text] [Related]
20. Nanohydroxyapatite Based Ceramic Carrier Promotes Bone Formation in a Femoral Neck Canal Defect in Osteoporotic Rats.
Qayoom I; Teotia AK; Kumar A
Biomacromolecules; 2020 Feb; 21(2):328-337. PubMed ID: 31637919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
